New Parkinson's disease therapeutics discovered by Ben-Gurion U researchers

(American Associates, Ben-Gurion University of the Negev) Dr. Claude Brodski, M.D., head of the BGU's Laboratory for Molecular Neuroscience, discovered that BMP5/7 signaling in neurons was significantly reduced in dopamine-producing brain cells, which could contribute to Parkinson's disease advancement.